ABT vs RKLB · P/E 25, rev $44.33B vs rev $434.4M
Abbott Laboratories (ABT) versus Rocket Lab USA Inc. (RKLB) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Rocket Lab USA Inc. (RKLB) is a aerospace & defense company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported RKLB revenue for 2026-06-30 was $434.4M. Net income was -$94.3M. RKLB currently screens at market cap $16.45B.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. RKLB currently screens at market cap $16.45B.
Not investment advice. Open the ABT and RKLB stock pages for the full models.
Not investment advice.